Progressive Care Monthly Revenues up 53% to $1.7 M
Post# of 1525
Posted On: 07/14/2016 10:14:20 AM
Progressive Care Monthly Revenues up 53% to $1.7 Million
http://finance.yahoo.com/quote/rxmd?ltr=1
MIAMI, FL--(Marketwired - July 14, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces record revenues for the month of June.
PharmCo recorded its highest ever revenues for the month of June 2016. On over 18,000 prescriptions filled, the Company reached $1.7 million in revenues. This is an 18% and 53% increase respectively over the same month last year. The compounding division continues to drive revenue growth as the Company has added new sales staff and begun shipping compounds to more states.
The Company is also resolving the outstanding requirement with Miami-Dade County to issue the building permits for the warehouse space. We expect permits to be issued before the end of the month and the build-out to begin shortly thereafter.
"It is exciting to not only meet our revenue goals for the month, but to exceed them," stated S. Parikh Mars, CEO. "We are moving forward with all of our growth objectives with more state applications filed, new sales staff hired, increased growth in MTM and 340B segments, and the imminent issuance of our building permits. We remain steadfast in our commitment to producing results, building cash and generating earnings."
http://finance.yahoo.com/quote/rxmd?ltr=1
MIAMI, FL--(Marketwired - July 14, 2016) - Progressive Care Inc. (OTC PINK: RXMD), through its subsidiary Pharmco LLC, a South Florida health services organization and provider of prescription pharmaceuticals specializing in health practice risk management, compounded medications, the sale of anti-retroviral medications and related medication therapy management, and the supply of prescription medications to long term care facilities, announces record revenues for the month of June.
PharmCo recorded its highest ever revenues for the month of June 2016. On over 18,000 prescriptions filled, the Company reached $1.7 million in revenues. This is an 18% and 53% increase respectively over the same month last year. The compounding division continues to drive revenue growth as the Company has added new sales staff and begun shipping compounds to more states.
The Company is also resolving the outstanding requirement with Miami-Dade County to issue the building permits for the warehouse space. We expect permits to be issued before the end of the month and the build-out to begin shortly thereafter.
"It is exciting to not only meet our revenue goals for the month, but to exceed them," stated S. Parikh Mars, CEO. "We are moving forward with all of our growth objectives with more state applications filed, new sales staff hired, increased growth in MTM and 340B segments, and the imminent issuance of our building permits. We remain steadfast in our commitment to producing results, building cash and generating earnings."
(0)
(0)